Save information for later
Sign Up

Learn About Alveolar Soft Part Sarcoma

What is the definition of Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue sarcoma. Although it has been described in a variety of locations, it most commonly develops on the lower extremities in adults and in the head and neck region of children. ASPS generally presents as a soft, pain-less lump that is often not associated with any additional signs and symptoms. In many cases, the condition is not diagnosed until the affected person develops symptoms of metastasis to other sites such as the lungs, bones, central nervous system and/or liver. The underlying cause of ASPS is poorly understood. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Alveolar Soft Part Sarcoma?
  • Alveolar soft part sarcoma
  • ASPS
Who are the top Alveolar Soft Part Sarcoma Local Doctors?
Piotr L. Rutkowski
Elite in Alveolar Soft Part Sarcoma
Elite in Alveolar Soft Part Sarcoma
Cracow Branch, 
Krakow, MA, PL 

Piotr Rutkowski practices in Krakow, Poland. Mr. Rutkowski is rated as an Elite expert by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Lymphadenectomy, and Pancreaticoduodenectomy.

Mark A. Dickson
Distinguished in Alveolar Soft Part Sarcoma
Hematology Oncology | Hematology | Oncology
Distinguished in Alveolar Soft Part Sarcoma
Hematology Oncology | Hematology | Oncology

Memorial Solid Tumor Group

160 E 53rd St, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Mark Dickson is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Dickson is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Todd W. Bauer
Distinguished in Alveolar Soft Part Sarcoma
Surgical Oncology
Distinguished in Alveolar Soft Part Sarcoma
Surgical Oncology

University Of Virginia Physicians Group

1215 Lee St, 
Charlottesville, VA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Todd Bauer is a Surgical Oncologist in Charlottesville, Virginia. Dr. Bauer is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Neuroendocrine Tumor, Hepatectomy, and Pancreaticoduodenectomy. Dr. Bauer is currently accepting new patients.

What are the latest Alveolar Soft Part Sarcoma Clinical Trials?
A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to treat certain cancers. Researchers want to find out if lower doses of this drug might provide the same benefit with fewer adverse effec...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors

Summary: Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced to decrease GVHD and PTLD and has demonstrated effectiveness for hematologic malignancies and non-malignant diseases additionally increasing the donor pool as to allow for haploidentical transplant to safely occur. While solid tumors can be h...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Alveolar Soft Part Sarcoma?